JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist

6935.0
-180.0-2.53%

20min DelayTrading Nov 7 10:14 JST

554.81BMarket Cap22.47P/E (Static)

COSMOS Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Aug 31, 2024

(FY)May 31, 2024

(Q4)May 31, 2024

(Q3)Feb 29, 2024

(Q2)Nov 30, 2023

(Q1)Aug 31, 2023

(FY)May 31, 2023

(Q4)May 31, 2023

(Q3)Feb 28, 2023

(Q2)Nov 30, 2022

Total revenue

8.35%261.84B

16.59%964.99B

12.77%249.68B

18.09%238.88B

18.64%234.78B

17.24%241.65B

9.57%827.7B

12.65%221.4B

7.74%202.29B

8.90%197.89B

Cost of revenue

6.49%207.28B

17.86%776.68B

13.59%201.04B

19.21%192.15B

20.31%188.86B

18.81%194.64B

9.11%658.98B

13.07%176.99B

7.11%161.19B

7.87%156.97B

Gross profit

16.06%54.56B

11.61%188.31B

9.53%48.64B

13.72%46.73B

12.21%45.92B

11.16%47.01B

11.40%168.72B

11.04%44.41B

10.30%41.1B

13.02%40.92B

Operating expense

13.05%42.98B

13.14%156.8B

12.16%40.88B

13.16%38.83B

13.47%39.07B

13.86%38.02B

13.92%138.59B

13.56%36.45B

13.10%34.32B

15.62%34.43B

Operating profit

28.80%11.58B

4.55%31.5B

-2.51%7.76B

16.53%7.9B

5.55%6.85B

1.02%8.99B

1.12%30.13B

0.81%7.96B

-1.99%6.78B

0.98%6.49B

Net non-operating interest income (expenses)

-375.00%-38M

-1,275.00%-55M

-600.00%-35M

-700.00%-6M

-700.00%-8M

-4M

-350.00%-5M

200.00%1M

Non-operating interest income

10.00%11M

-6.38%44M

-8.33%11M

0.00%12M

-8.33%11M

-9.09%10M

-9.62%47M

-14.29%12M

-7.69%12M

Non-operating interest expense

172.22%49M

94.12%99M

170.59%46M

63.64%18M

54.55%17M

50.00%18M

-1.92%51M

41.67%17M

-15.38%11M

-21.43%11M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-268.85%-225M

-86.17%-579M

-300.66%-609M

723.08%162M

21.11%-71M

-41.86%-61M

-266.31%-311M

-38.18%-152M

-116.88%-26M

-139.30%-90M

Less:Restructuring and mergern&acquisition

-25.93%20M

-63.49%69M

-63.83%51M

-311.11%-19M

-58.33%10M

80.00%27M

20.38%189M

95.83%141M

-79.07%9M

-40.00%24M

Less:Other special charges

502.94%205M

-120.49%-25M

109.09%23M

-941.18%-143M

-7.58%61M

21.43%34M

135.47%122M

-71.05%11M

108.63%17M

124.54%66M

Less:Write off

----

--535M

----

--0

----

Other non-operating income (expenses)

5.03%751M

-3.61%2.85B

-10.34%659M

-5.35%672M

2.28%807M

-1.52%715M

-3.46%2.96B

-14.83%735M

3.35%710M

2.33%789M

Income before tax

25.22%12.07B

2.89%33.72B

-8.95%7.78B

16.89%8.73B

5.49%7.58B

0.57%9.64B

-0.83%32.77B

-1.27%8.54B

-3.78%7.47B

-3.23%7.18B

Income tax

25.38%3.92B

3.23%9.27B

-33.69%681M

19.17%2.96B

5.54%2.5B

0.94%3.13B

-9.27%8.98B

-47.33%1.03B

-2.70%2.48B

-2.27%2.37B

Net income

25.12%8.14B

2.76%24.45B

-5.55%7.1B

15.77%5.77B

5.42%5.08B

0.42%6.51B

2.77%23.8B

12.15%7.51B

-4.34%4.98B

-3.68%4.82B

Net income continuous operations

25.14%8.14B

2.76%24.45B

-5.56%7.1B

15.75%5.77B

5.46%5.08B

0.40%6.51B

2.77%23.8B

12.13%7.51B

-4.30%4.99B

-3.70%4.82B

Noncontrolling interests

Net income attributable to the company

25.12%8.14B

2.76%24.45B

-5.55%7.1B

15.77%5.77B

5.42%5.08B

0.42%6.51B

2.77%23.8B

12.15%7.51B

-4.34%4.98B

-3.68%4.82B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

25.12%8.14B

2.76%24.45B

-5.55%7.1B

15.77%5.77B

5.42%5.08B

0.42%6.51B

2.77%23.8B

12.15%7.51B

-4.34%4.98B

-3.68%4.82B

Gross dividend payment

Basic earnings per share

25.03%102.74

2.71%308.61

-5.62%89.54

15.67%72.805

5.36%64.09

0.41%82.175

2.77%300.48

12.14%94.87

-4.32%62.94

-3.68%60.83

Diluted earnings per share

25.03%102.74

2.71%308.61

-5.62%89.54

15.68%72.8005

5.36%64.09

0.41%82.175

2.77%300.48

12.14%94.87

-4.34%62.931

-3.68%60.83

Dividend per share

20.00%60

4.35%30

41.18%30

25.00%50

43.75%28.75

6.25%21.25

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Aug 31, 2024	(FY)May 31, 2024	(Q4)May 31, 2024	(Q3)Feb 29, 2024	(Q2)Nov 30, 2023	(Q1)Aug 31, 2023	(FY)May 31, 2023	(Q4)May 31, 2023	(Q3)Feb 28, 2023	(Q2)Nov 30, 2022
Total revenue	8.35%261.84B	16.59%964.99B	12.77%249.68B	18.09%238.88B	18.64%234.78B	17.24%241.65B	9.57%827.7B	12.65%221.4B	7.74%202.29B	8.90%197.89B
Cost of revenue	6.49%207.28B	17.86%776.68B	13.59%201.04B	19.21%192.15B	20.31%188.86B	18.81%194.64B	9.11%658.98B	13.07%176.99B	7.11%161.19B	7.87%156.97B
Gross profit	16.06%54.56B	11.61%188.31B	9.53%48.64B	13.72%46.73B	12.21%45.92B	11.16%47.01B	11.40%168.72B	11.04%44.41B	10.30%41.1B	13.02%40.92B
Operating expense	13.05%42.98B	13.14%156.8B	12.16%40.88B	13.16%38.83B	13.47%39.07B	13.86%38.02B	13.92%138.59B	13.56%36.45B	13.10%34.32B	15.62%34.43B
Operating profit	28.80%11.58B	4.55%31.5B	-2.51%7.76B	16.53%7.9B	5.55%6.85B	1.02%8.99B	1.12%30.13B	0.81%7.96B	-1.99%6.78B	0.98%6.49B
Net non-operating interest income (expenses)	-375.00%-38M	-1,275.00%-55M	-600.00%-35M	-700.00%-6M	-700.00%-6M	-700.00%-8M	-4M	-350.00%-5M	1M	200.00%1M
Non-operating interest income	10.00%11M	-6.38%44M	-8.33%11M	0.00%12M	-8.33%11M	-9.09%10M	-9.62%47M	-14.29%12M	-7.69%12M	-7.69%12M
Non-operating interest expense	172.22%49M	94.12%99M	170.59%46M	63.64%18M	54.55%17M	50.00%18M	-1.92%51M	41.67%17M	-15.38%11M	-21.43%11M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-268.85%-225M	-86.17%-579M	-300.66%-609M	723.08%162M	21.11%-71M	-41.86%-61M	-266.31%-311M	-38.18%-152M	-116.88%-26M	-139.30%-90M
Less:Restructuring and mergern&acquisition	-25.93%20M	-63.49%69M	-63.83%51M	-311.11%-19M	-58.33%10M	80.00%27M	20.38%189M	95.83%141M	-79.07%9M	-40.00%24M
Less:Other special charges	502.94%205M	-120.49%-25M	109.09%23M	-941.18%-143M	-7.58%61M	21.43%34M	135.47%122M	-71.05%11M	108.63%17M	124.54%66M
Less:Write off	----	--535M	----	----	----	----	--0	----	----	----
Other non-operating income (expenses)	5.03%751M	-3.61%2.85B	-10.34%659M	-5.35%672M	2.28%807M	-1.52%715M	-3.46%2.96B	-14.83%735M	3.35%710M	2.33%789M
Income before tax	25.22%12.07B	2.89%33.72B	-8.95%7.78B	16.89%8.73B	5.49%7.58B	0.57%9.64B	-0.83%32.77B	-1.27%8.54B	-3.78%7.47B	-3.23%7.18B
Income tax	25.38%3.92B	3.23%9.27B	-33.69%681M	19.17%2.96B	5.54%2.5B	0.94%3.13B	-9.27%8.98B	-47.33%1.03B	-2.70%2.48B	-2.27%2.37B
Net income	25.12%8.14B	2.76%24.45B	-5.55%7.1B	15.77%5.77B	5.42%5.08B	0.42%6.51B	2.77%23.8B	12.15%7.51B	-4.34%4.98B	-3.68%4.82B
Net income continuous operations	25.14%8.14B	2.76%24.45B	-5.56%7.1B	15.75%5.77B	5.46%5.08B	0.40%6.51B	2.77%23.8B	12.13%7.51B	-4.30%4.99B	-3.70%4.82B
Noncontrolling interests
Net income attributable to the company	25.12%8.14B	2.76%24.45B	-5.55%7.1B	15.77%5.77B	5.42%5.08B	0.42%6.51B	2.77%23.8B	12.15%7.51B	-4.34%4.98B	-3.68%4.82B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	25.12%8.14B	2.76%24.45B	-5.55%7.1B	15.77%5.77B	5.42%5.08B	0.42%6.51B	2.77%23.8B	12.15%7.51B	-4.34%4.98B	-3.68%4.82B
Gross dividend payment
Basic earnings per share	25.03%102.74	2.71%308.61	-5.62%89.54	15.67%72.805	5.36%64.09	0.41%82.175	2.77%300.48	12.14%94.87	-4.32%62.94	-3.68%60.83
Diluted earnings per share	25.03%102.74	2.71%308.61	-5.62%89.54	15.68%72.8005	5.36%64.09	0.41%82.175	2.77%300.48	12.14%94.87	-4.34%62.931	-3.68%60.83
Dividend per share	0	20.00%60	4.35%30	0	41.18%30	0	25.00%50	43.75%28.75	0	6.25%21.25
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data